Effectiveness of a structured, framework-based approach to implementation: the Researching Effective Approaches to Cleaning in Hospitals (REACH) Trial.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
18 02 2020
Historique:
received: 20 10 2019
accepted: 06 02 2020
entrez: 20 2 2020
pubmed: 20 2 2020
medline: 19 5 2021
Statut: epublish

Résumé

Implementing sustainable practice change in hospital cleaning has proven to be an ongoing challenge in reducing healthcare associated infections. The purpose of this study was to develop a reliable framework-based approach to implement and quantitatively evaluate the implementation of evidence-based practice change in hospital cleaning. The Researching Effective Approaches to Cleaning in Hospitals (REACH) trial was a pragmatic, stepped-wedge randomised trial of an environmental cleaning bundle implemented in 11 Australian hospitals from 2016 to 2017. Using a structured multi-step approach, we adapted the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework to support rigorous and tailored implementation of the cleaning bundle intervention in eleven diverse and complex settings. To evaluate the effectiveness of this strategy we examined post-intervention cleaning bundle alignment calculated as a score (an implementation measure) and cleaning performance audit data collected using ultraviolet (UV) gel markers (an outcome measure). We successfully implemented the bundle and observed improvements in cleaning practice and performance, regardless of hospital size, intervention duration and contextual issues such as staff and organisational readiness at baseline. There was a positive association between bundle alignment scores and cleaning performance at baseline. This diminished over the duration of the intervention, as hospitals with lower baseline scores were able to implement practice change successfully. Using a structured framework-based approach allows for pragmatic and successful implementation of clinical trials across diverse settings, and assists with quantitative evaluation of practice change. Australia New Zealand Clinical Trial Registry ACTRN12615000325505, registered on 4 September 2015.

Sections du résumé

BACKGROUND
Implementing sustainable practice change in hospital cleaning has proven to be an ongoing challenge in reducing healthcare associated infections. The purpose of this study was to develop a reliable framework-based approach to implement and quantitatively evaluate the implementation of evidence-based practice change in hospital cleaning.
DESIGN/METHODS
The Researching Effective Approaches to Cleaning in Hospitals (REACH) trial was a pragmatic, stepped-wedge randomised trial of an environmental cleaning bundle implemented in 11 Australian hospitals from 2016 to 2017. Using a structured multi-step approach, we adapted the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework to support rigorous and tailored implementation of the cleaning bundle intervention in eleven diverse and complex settings. To evaluate the effectiveness of this strategy we examined post-intervention cleaning bundle alignment calculated as a score (an implementation measure) and cleaning performance audit data collected using ultraviolet (UV) gel markers (an outcome measure).
RESULTS
We successfully implemented the bundle and observed improvements in cleaning practice and performance, regardless of hospital size, intervention duration and contextual issues such as staff and organisational readiness at baseline. There was a positive association between bundle alignment scores and cleaning performance at baseline. This diminished over the duration of the intervention, as hospitals with lower baseline scores were able to implement practice change successfully.
CONCLUSION
Using a structured framework-based approach allows for pragmatic and successful implementation of clinical trials across diverse settings, and assists with quantitative evaluation of practice change.
TRIAL REGISTRATION
Australia New Zealand Clinical Trial Registry ACTRN12615000325505, registered on 4 September 2015.

Identifiants

pubmed: 32070419
doi: 10.1186/s13756-020-0694-0
pii: 10.1186/s13756-020-0694-0
pmc: PMC7029491
doi:

Banques de données

ANZCTR
['ACTRN12615000325505']

Types de publication

Journal Article Pragmatic Clinical Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

35

Subventions

Organisme : National Health and Medical Research Council
ID : GNT1076006
Pays : International

Références

Eval Program Plann. 2014 Oct;46:58-71
pubmed: 24934642
Implement Sci. 2018 Feb 08;13(1):26
pubmed: 29422080
Am J Infect Control. 2018 Sep;46(9):980-985
pubmed: 29550084
Ann Intern Med. 2015 Oct 20;163(8):598-607
pubmed: 26258903
J Hosp Infect. 2015 Nov;91(3):211-7
pubmed: 26365827
Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1473-81
pubmed: 21499954
Res Theory Nurs Pract. 2016 Aug 1;30(3):258-271
pubmed: 28304270
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1492-1495
pubmed: 27619896
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Health Promot Int. 2013 Sep;28(3):285-98
pubmed: 22241853
Am J Infect Control. 2019 Jun;47(6):688-692
pubmed: 30850251
Implement Sci. 2016 Mar 10;11:33
pubmed: 27013464
Crit Care Med. 2010 Apr;38(4):1054-9
pubmed: 20081531
Lancet Infect Dis. 2019 Apr;19(4):410-418
pubmed: 30858014
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Implement Sci. 2016 Mar 24;11:44
pubmed: 27009342
Clin Infect Dis. 2019 Jul 30;:
pubmed: 31359053
Am J Infect Control. 2014 Oct;42(10 Suppl):S223-9
pubmed: 25239714
Infect Control Hosp Epidemiol. 2013 Oct;34(10):1048-54
pubmed: 24018921
BMJ Open. 2017 Aug 11;7(8):e014384
pubmed: 28801388

Auteurs

Lisa Hall (L)

School of Public Health, University of Queensland, 288 Herston Road, Herston, Queensland, 4006, Australia. l.hall3@uq.edu.au.
School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia. l.hall3@uq.edu.au.

Nicole M White (NM)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Australian Centre for Health Service Innovation, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Michelle Allen (M)

Abt Associates, Brisbane, Queensland, Australia.

Alison Farrington (A)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Australian Centre for Health Service Innovation, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Brett G Mitchell (BG)

Discipline of Nursing, Avondale College of Higher Education, Cooranbong, New South Wales, Australia.
School of Nursing and Midwifery, University of Newcastle, Newcastle, New South Wales, Australia.

Katie Page (K)

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Ultimo, New South Wales, Australia.

Kate Halton (K)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.

Thomas V Riley (TV)

School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia.

Christian A Gericke (CA)

School of Clinical Medicine, University of Queensland, Brisbane, Queensland, Australia.

Nicholas Graves (N)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.

Anne Gardner (A)

School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH